✦ LIBER ✦

Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?

✍ Scribed by Peter J. Zimetbaum; Amit Thosani; Hsing-Ting Yu; Yan Xiong; Jay Lin; Prajesh Kothawala; Matthew Emons

Book ID: 116212635
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 980 KB
Volume: 123
Category: Article
ISSN: 1555-7162
DOI: 10.1016/j.amjmed.2009.11.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Psychosocial risk factors for adverse ou

Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin

✍ Daniel P. Schauer; Charles J. Moomaw; Mark Wess; Thomas Webb; Mark H. Eckman 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Major Bleeding in Patients With Atrial F

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin

✍ Hylek, Elaine M.; Held, Claes; Alexander, John H.; Lopes, Renato D.; De Caterina 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Ischemic stroke in patients with atrial

Ischemic stroke in patients with atrial fibrillation receiving oral anticoagulation

✍ Pujol Lereis, Virginia A.; Ameriso, Sebastian; Povedano, Guillermo P.; Ameriso, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 246 KB

STROKE AND BLEEDING IN OLDER PATIENTS WI

STROKE AND BLEEDING IN OLDER PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN

✍ Tsadok, Meytal Avgil; Jackevicius, Cynthia; Essebag, Vidal; Eisenberg, Mark; Rah 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 236 KB

WARFARIN AND THE RISK OF STROKE AND BLEE

WARFARIN AND THE RISK OF STROKE AND BLEEDING IN ATRIAL FIBRILLATION PATIENTS UNDERGOING DIALYSIS

✍ Tsadok, Meytal Avgil; Jackevicius, Cynthia; Eisenberg, Mark; Shah, Mitesh; Esseb 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Medical Costs of Oral Anticoagulants vs

Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks

✍ Deitelzweig, Steve; Amin, Alpesh; Jing, Yonghua; Makenbaeva, Dinara; Wiederkehr, 📂 Article 📅 2013 🏛 Springer Healthcare Communications 🌐 English ⚖ 342 KB

## Introduction The Apixaban for the Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE), Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY), and Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevent